Lista de obras - Fiorella D'Auria - Dominio Público Uruguay

A shorter time to the first treatment may be predicted by the absolute number of regulatory T-cells in patients with Rai stage 0 chronic lymphocytic leukemia.

artículo científico publicado en 2012

An urologic face of chronic lymphocytic leukemia: sequential prostatic and penis localization

artículo científico publicado en 2013

Biological and clinical relevance of miRNA expression signatures in primary plasma cell leukemia.

artículo científico publicado en 2013

Chronic Lymphocytic Leukemia After Chronic Myeloid Leukemia in the Same Patient: Two Different Genomic Events and a Common Treatment?

artículo científico publicado en 2012

Cytological and histological detection of amyloid deposits in bone marrow of patients affected by multiple myeloma

artículo científico publicado en 2011

Efficacy of bortezomib, lenalidomide and dexamethasone (VRD) in secondary plasma cell leukaemia

artículo científico publicado en 2012

Employment of oligodeoxynucleotide plus interleukin-2 improves cytogenetic analysis in splenic marginal zone lymphoma

artículo científico publicado en 2011

Erythroid response and decrease of WT1 expression after proteasome inhibition by bortezomib in myelodysplastic syndromes

artículo científico publicado en 2010

Genome-wide analysis of primary plasma cell leukemia identifies recurrent imbalances associated with changes in transcriptional profiles

article

Heavy/light chain ratio for the assessment of minimal residual disease in myeloma patients achieving complete response

artículo científico publicado en 2017

Lenalidomide differently modulates CD20 antigen surface expression on chronic lymphocytic leukemia B-cells

artículo científico publicado en 2015

Modulation of CD20 antigen expression after rituximab treatment: a retrospective study in patients with chronic lymphocytic leukemia.

artículo científico publicado en 2010

Peg-filgrastim versus filgrastim after autologous stem cell tranplantation: case-control study in patients with multiple myeloma and review of the literature

artículo científico publicado en 2007

Positive effects on hematopoiesis in patients with myelodysplastic syndrome receiving deferasirox as oral iron chelation therapy: a brief review

artículo científico publicado en 2010

Primary plasma cell leukemia in the era of new drugs: has something changed?

artículo científico publicado en 2011

Regulatory T-cells in chronic lymphocytic leukemia and autoimmune diseases

artículo científico publicado en 2012

Response to recombinant erythropoietin alpha, without the adjunct of granulocyte-colony stimulating factor, is associated with a longer survival in patients with transfusion-dependent myelodysplastic syndromes

artículo científico publicado en 2009

Role of thalidomide in previously untreated patients with multiple myeloma.

scientific article published on October 2008

Salvage therapy with lenalidomide and dexamethasone in relapsed primary plasma cell leukemia

artículo científico publicado en 2008

The clinical and biological role of CD20 membrane antigen modulation under immunotherapy with anti-CD20 monoclonal antibody rituximab in lymphoprolipherative neoplastic disorders

artículo científico publicado en 2011

The iron chelator deferasirox affects redox signalling in haematopoietic stem/progenitor cells.

artículo científico publicado en 2015

Transcriptional characterization of a prospective series of primary plasma cell leukemia revealed signatures associated with tumor progression and poorer outcome.

artículo científico publicado en 2013

Validation of Vacuum-Based Refrigerated System for Biobanking Tissue Preservation: Analysis of Cellular Morphology, Protein Stability, and RNA Quality

artículo científico publicado en 2014

Lista de obras de Fiorella D'Auria

A shorter time to the first treatment may be predicted by the absolute number of regulatory T-cells in patients with Rai stage 0 chronic lymphocytic leukemia.

An urologic face of chronic lymphocytic leukemia: sequential prostatic and penis localization

Biological and clinical relevance of miRNA expression signatures in primary plasma cell leukemia.

Chronic Lymphocytic Leukemia After Chronic Myeloid Leukemia in the Same Patient: Two Different Genomic Events and a Common Treatment?

Cytological and histological detection of amyloid deposits in bone marrow of patients affected by multiple myeloma

Efficacy of bortezomib, lenalidomide and dexamethasone (VRD) in secondary plasma cell leukaemia

Employment of oligodeoxynucleotide plus interleukin-2 improves cytogenetic analysis in splenic marginal zone lymphoma

Erythroid response and decrease of WT1 expression after proteasome inhibition by bortezomib in myelodysplastic syndromes

Genome-wide analysis of primary plasma cell leukemia identifies recurrent imbalances associated with changes in transcriptional profiles

Heavy/light chain ratio for the assessment of minimal residual disease in myeloma patients achieving complete response

Lenalidomide differently modulates CD20 antigen surface expression on chronic lymphocytic leukemia B-cells

Modulation of CD20 antigen expression after rituximab treatment: a retrospective study in patients with chronic lymphocytic leukemia.

Peg-filgrastim versus filgrastim after autologous stem cell tranplantation: case-control study in patients with multiple myeloma and review of the literature

Positive effects on hematopoiesis in patients with myelodysplastic syndrome receiving deferasirox as oral iron chelation therapy: a brief review

Primary plasma cell leukemia in the era of new drugs: has something changed?

Regulatory T-cells in chronic lymphocytic leukemia and autoimmune diseases

Response to recombinant erythropoietin alpha, without the adjunct of granulocyte-colony stimulating factor, is associated with a longer survival in patients with transfusion-dependent myelodysplastic syndromes

Role of thalidomide in previously untreated patients with multiple myeloma.

Salvage therapy with lenalidomide and dexamethasone in relapsed primary plasma cell leukemia

The clinical and biological role of CD20 membrane antigen modulation under immunotherapy with anti-CD20 monoclonal antibody rituximab in lymphoprolipherative neoplastic disorders

The iron chelator deferasirox affects redox signalling in haematopoietic stem/progenitor cells.

Transcriptional characterization of a prospective series of primary plasma cell leukemia revealed signatures associated with tumor progression and poorer outcome.

Validation of Vacuum-Based Refrigerated System for Biobanking Tissue Preservation: Analysis of Cellular Morphology, Protein Stability, and RNA Quality